. Activation of mast cells by systemic hypoxia, but not by local hypoxia, mediates increased leukocyte-endothelial adherence in cremaster venules. J Appl Physiol 95: 2495-2502. First published August 29, 2003 10.1152/japplphysiol.00735.2003.-Systemic hypoxia, produced by lowering inspired PO 2, induces a rapid inflammation in several microcirculations, including cremaster muscle. Mast cell activation is a necessary element of this response. Selective reduction of cremaster microvascular PO 2 (Pm O 2 ) with normal systemic arterial PO2 (PaO 2 ; cremaster hypoxia/systemic normoxia), however, does not elicit increased leukocyte-endothelial adherence (LEA) in cremaster venules. This could be due to a short time of leukocyte exposure to the hypoxic cremaster environment. Conversely, LEA increases when Pa O 2 is lowered, while cremaster Pm O 2 remains high (cremaster normoxia/systemic hypoxia). An alternative explanation of these results is that a mediator released from a central site during systemic hypoxia initiates the inflammatory cascade. We hypothesized that if this is the case, cremaster mast cells would be activated during cremaster normoxia/systemic hypoxia, but not during cremaster hypoxia/systemic normoxia. The microcirculation of rat cremaster muscles was visualized by using intravital microscopy. Cremaster Pm O 2 was measured with a phosphorescence quenching method. Cremaster hypoxia/ systemic normoxia (Pm O 2 7 Ϯ 1 Torr, PaO 2 87 Ϯ 2 Torr) did not increase LEA; however, topical application of the mast cell activator compound 48/80 under these conditions did increase LEA. The effect of compound 48/80 on LEA was blocked by topical cromolyn, a mast cell stabilizer. LEA increased during cremaster normoxia/systemic hypoxia, (Pm O 2 64 Ϯ 5 Torr, PaO 2 33 Ϯ 2 Torr); this increase was blocked by topical cromolyn. The results suggest that mast cell stimulation occurs only when Pa O 2 is reduced, independent of cremaster Pm O 2 , and support the idea of a mediator that is released during systemic hypoxia and initiates the inflammatory cascade. microvascular inflammation; microvascular PO 2; muscle microcirculation; compound 48/80; cromolyn SYSTEMIC HYPOXIA, INDUCED BY a reduction in inspired PO 2 , results in a rapid microvascular inflammatory response characterized by elevated levels of reactive O 2 species (ROS) (20), depletion of nitric oxide (NO) (18), increased leukocyteendothelial adhesive interactions (21), leukocyte emigration to the perivascular space, and elevated vascular permeability (20). These effects have been documented in the mesenteric, pial, and skeletal muscle microcirculations, suggesting a widespread nature of this response (7).
SYSTEMIC HYPOXIA, INDUCED BY a reduction in inspired PO 2 , results in a rapid microvascular inflammatory response characterized by elevated levels of reactive O 2 species (ROS) (20) , depletion of nitric oxide (NO) (18) , increased leukocyteendothelial adhesive interactions (21) , leukocyte emigration to the perivascular space, and elevated vascular permeability (20) . These effects have been documented in the mesenteric, pial, and skeletal muscle microcirculations, suggesting a widespread nature of this response (7) .
Mast cells play an early, key role in the microvascular effects of hypoxia. Activation of mast cells with the use of compound 48/80 in normoxic animals produces an inflammatory response similar to that elicited by hypoxia; in addition, mast cells degranulate during hypoxia, and blockade of hypoxia-induced degranulation with the mast cell stabilizer cromolyn prevents or attenuates the hypoxic microvascular inflammatory response (19) . An alteration of the ROS-NO balance appears to be involved in the activation of mast cells during hypoxia, since both antioxidants and NO donors prevent the activation of mast cells (19) as well as the microvascular inflammation that accompanies hypoxia (20) .
The mechanism by which a reduction in the inspired PO 2 leads to a rapid and widespread microvascular inflammation is not clear. Hypoxia results in increased ROS generation in isolated cardiomyocytes (6) and endothelial cells (1, 13) , elevated expression of adhesion molecules in isolated leukocytes (12, 15, 17) , and increased adherence of leukocytes to cultured human umbilical vein endothelial cells (2, 3) , suggesting that the local reduction in PO 2 sets in motion the processes involved in the microvascular inflammation seen in the intact animal. On the other hand, a dissociation between cremaster microvascular PO 2 (Pm O 2 ) and hypoxia-induced leukocyte adherence to cremaster venules has been shown in intact rats (16) . Selective reduction of cremaster muscle Pm O 2 under conditions of normal systemic arterial PO 2 (Pa O 2 ) was not accompanied by increased adherence of leukocytes to cremaster venules in intact rats; in contrast, leukocyte adherence occurred when cremaster Pm O 2 was maintained elevated during systemic hypoxia (16) . Absence of leukocyte-endothelial adherence during selective cremaster hypoxia could be due to insufficient time for leukocytes to become fully activated during their transit through the hypoxic cremaster. However, if this is the case, the observation that leukocytes adhere to normoxic cremaster venules when rats breathe a hypoxic gas mixture (16) would suggest that only leukocytes, and not endothelial cells, need to become hypoxic for leukocyte-endothelial cell adherence to occur. Alternatively, the dissociation between Pm O 2 and leukocyte-endothelial adherence could be explained by the release of a mediator triggered by the reduction of PO 2 at some central site. The microvascular response to this hypothetical mediator would be independent of the Pm O 2 prevalent at the site where inflammation develops.
The present study continues our investigation of the relationship between local Pm O 2 and hypoxia-induced microvascular inflammation in the cremaster muscle. Experiments were designed to further explore the possibility that systemic hypoxia results in the release of an intermediary substance, which sets in motion the microvascular inflammatory response. Based on the observation that mast cell activation is a necessary event in the development of hypoxia-induced inflammation, we reasoned that if a mediator released from a distant site is responsible for the initiation of the microvascular inflammation in the cremaster, cremaster mast cells would be activated during reductions in Pa O 2 , even if local Pm O 2 is elevated. Conversely, selective cremaster hypoxia in the presence of systemic normoxia would not be accompanied by mast cell activation.
Evidence of mast cell activation was obtained indirectly from the effects of known mast cell stimulants and stabilizers on leukocyte-endothelial adherence and confirmed by direct observation of mast cell degranulation.
METHODS
All procedures were approved by the Animal Care and Use Committee of the University of Kansas Medical Center, an institution accredited by the American Association for the Accreditation of Laboratory Animal Care.
Surgical preparation. Male Sprague-Dawley rats, 175-225 g, were anesthetized with urethane (1.5 g/kg im) after an overnight fast with free access to water. Body temperature was maintained at 36-38°C by using a homeothermic blanket system connected to an intrarectal temperature probe. PE-50 catheters were inserted in the jugular vein and the carotid artery. Lactated Ringer solution was infused continuously via the jugular vein at a rate of 2 ml/h. Arterial blood pressure was continuously monitored with a digital blood pressure monitor connected to the carotid artery catheter. A tracheotomy was performed, and PE-240 tubing was connected to a rodent nonrebreathing two-way valve. The animals breathed spontaneously throughout the experiment.
Intravital microscopy. The right cremaster muscle was prepared for intravital microscopy as described previously (4) . The rat was placed on the platform of a Nikon E600 FN microscope, and the cremaster was spread over a hollow Lucite cylinder, the top of which was sealed with a glass slide. Water was circulated through the cylinder to maintain muscle temperature at 37°C. Muscle temperature was monitored continuously via a thermistor placed underneath the muscle. The cremaster was covered with Saran wrap throughout the experiment.
In experiments in which cremaster Pm O 2 was altered independently of systemic PO 2, the cremaster was spread over a hollow plastic cylinder, through which warm, humidified gas of the desired PO 2 was circulated, and covered by a plastic dome, through which the same gas was flushed. The muscle was not covered with Saran wrap in these experiments. Muscle temperature was maintained at 37°C by means of a heating lamp.
Images of the cremaster microcirculation (ϫ40 objective) were recorded on a videocassette recorder with a time-date generator. Straight, unbranched venules of 100 m in length and 20-40 m in diameter, with fewer than three adherent leukocytes in a 100-m segment and no adjacent lymphatics, were selected for microscopic observation. Venular diameter was measured by using a video caliper. An optical Doppler velocimeter was used to measure venular centerline red blood cell velocity. Average red blood cell velocity was calculated as centerline velocity/1.6 (5). Wall shear rate, which represents the force generated at the vessel wall by the movement of blood, was calculated as 8 ϫ (average red blood cell velocity/venular diameter) (8) . Adherent leukocytes were defined as leukocytes that remained stationary for Ͼ30 s. Leukocyte adherence was expressed as the number of adherent leukocytes per 100 m of vessel length.
Measurement of Pm O 2 .
A method based on the PO2 dependence of phosphorescence lifetime was used to determine Pm O 2 (14) . The measurement of Pm O 2 was carried out in separate experiments in which the cremaster was prepared as described above, but the microcirculation was not visualized with intravital microscopy. The oxyphor Pd-porphyrin dendrimer (R2) was injected intravenously (16 mg/kg). At this concentration, R2 binds completely to albumin (9); furthermore, R2 has a negative net charge, which facilitates restriction to the vascular space. Phosphorescence was measured by using a phosphorometer (Oxyspot, Medical Systems, Greenvale, NY) with a bifurcated light guide positioned 2-4 mm above the cremaster. The excitation light emitted from the light guide reached a circular area of the cremaster of ϳ1 mm in diameter and ϳ500 m deep. The phosphorescence signal was averaged over 200 ms for each measurement. Pm O 2 was measured every minute. The value of Pm O 2 obtained is a weighted average determined by the relative proportion of blood contained in the arterioles, capillaries, and venules of the muscle. An excellent correlation was observed between PO 2 values obtained by using a PO 2 electrode and the phosphorescence quenching method in the same blood sample (16) .
Assessment of mast cell activation. In some experiments, the cremaster was prepared for histological visualization of mast cells. The muscle was excised and fixed in Zamboni's solution for 24-48 h, after which it was transferred to a 30% sucrose solution, frozen in dry ice, sliced in ϳ20-m-thick slices, and stained in 1% toluidine blue solution.
Experimental protocols. In all protocols, ϳ45 min were allowed for the animals to recover from surgery. Approximately half of the experiments were directed to study leukocyte-endothelial interactions via intravital microscopy; in the remaining experiments, Pm O 2 was measured as described above. Arterial blood samples for measurement of pH, PO 2, and PCO2 were obtained at the end of each experimental period.
Systemic hypoxia. These experiments consisted of a 20-min normoxic control period, a 10-min hypoxia period in which the animals spontaneously breathed 10% O 2-90% N2, and a 10-min normoxic recovery period. Pm O 2 was measured every minute.
In a subset of experiments using this protocol, the mast cell stabilizer cromolyn (2 ml, 0.11 mg/ml) was applied topically to the cremaster muscle at 10 min of the normoxic control period, and the application was repeated immediately before the hypoxic and normoxic recovery periods.
Cremaster hypoxia, systemic normoxia. In these experiments, the animals breathed room air throughout the experiment. The cremaster was equilibrated as described above with a gas mixture of 10% O 2-5% CO2-85% N2. After a 20-min control period, local hypoxia of the cremaster was produced by changing the gas mixture equilibrating the muscle to 95% N 2-5% CO2 while the animal continued breathing room air. Fig. 1 . Top: time course of leukocyte-endothelial adherence for the systemic hypoxia experiments. Systemic hypoxia was induced by breathing 10% O2. F, Untreated animals, n ϭ 6; E, cromolyn-treated animals, n ϭ 6. Cromolyn (2 ml, 0.11 mg/ml) was topically applied on the cremaster at 10 min of the normoxic control period and immediately before the hypoxia and the normoxic recovery periods. Bottom: time course of microvascular PO2 (Pm O 2 ). Untreated animals (F), n ϭ 6; cromolyn-treated animals (E), n ϭ 5. The numerical inset indicates mean arterial PO2 (PaO 2 ) values (Torr) in each period. Fig. 2 . Microphotographs showing toluidine blue-stained cremaster mast cells. In both cases, the muscles were excised after 10 min of hypoxic exposure in an untreated rat (left) and in a rat treated with topical cromolyn (right). Fig. 3 . Top: time course of leukocyte-endothelial adherence for the cremaster hypoxia/systemic normoxia experiments. Cremaster hypoxia was induced by equilibrating the cremaster with 95% N2-5% CO2. The rat breathed room air throughout the experiment. F, Untreated animals (n ϭ 6); ‚, compound 48/80 (C48/80; 2 ml, 15 g/ml) applied topically immediately before the onset of hypoxia (n ϭ 6); E, cromolyn (2 ml, 0.11 mg/ml) was applied topically at 10 min of the normoxic control, immediately before the onset of hypoxia and immediately before the start of the normoxic recovery, and C48/80 (2 ml, 15 g/ml) was applied topically immediately before the onset of hypoxia (n ϭ 6). Bottom: time course of Pm O 2 . Untreated: n ϭ 6; C48/80: n ϭ 5; C48/80 plus cromolyn: n ϭ 4. The numerical inset indicates mean PaO 2 values (Torr) in each period. Fig. 4 . Microphotographs showing toluidine blue-stained cremaster mast cells in 3 rats of the cremaster hypoxia/ systemic normoxia protocol. In all cases, the muscles were excised after 10 min of selective lowering of cremaster Pm O 2 in an untreated rat (left), in a rat treated with topical C48/80 (middle), and in a rat treated with topical cromolyn, followed 10 min later by topical application of C48/80 (right). 5 . Top: time course of leukocyte-endothelial adherence for the cremaster normoxia/systemic hypoxia experiments. The cremaster muscle was equilibrated with 10% O2-5% CO2-85% N2 throughout the experiment. Systemic hypoxia was induced by breathing 10% O2-90% N2. F, Untreated rats (n ϭ 6); E, cromolyn (2 ml, 0.11 mg/ml) was applied topically at 10 min of the normoxic control, immediately before the onset of hypoxia, and immediately before the start of the normoxic recovery (n ϭ 6). Bottom: time course of Pm O 2 . Untreated: n ϭ 6; cromolyn: n ϭ 5. The numerical inset indicates mean PaO 2 values (Torr) in each period. Fig. 6 . Microphotographs showing toluidine blue-stained cremaster mast cells in 2 rats of the cremaster normoxia/systemic hypoxia protocol. In both cases, the muscles were excised after 10 min of breathing 10% O2 in an untreated rat (left) and in a rat treated with topical cromolyn (right).
After 10 min of cremaster hypoxia, the gas mixture equilibrating the muscle was returned to 10% O 2-5% CO2-85% N2.
In a second series of experiments using this protocol, the mast cell activator compound 48/80 (2 ml, 15 g /ml) was applied topically immediately before the onset of cremaster hypoxia.
In a third series of experiments, cromolyn (2 ml, 0.11 mg/ml) was applied topically at 10 min of the normoxic control and immediately before hypoxia and recovery. Compound 48/80 (2 ml, 15 g /ml) was applied topically immediately before the onset of local hypoxia.
Cremaster normoxia, systemic hypoxia. In these experiments, the cremaster was equilibrated with a gas mixture of 10% O 2-5% CO2-85% N2 throughout the experiment. After a 20-min normoxic control period, the animal breathed 10% O 2-90% N 2 while the muscle continued to be equilibrated with 10% O 2-5% CO2-85% N2. The period of systemic hypoxia lasted 10 min and was followed by a 10-min normoxic recovery period.
In a second series of experiments with this protocol, the mast cell stabilizer cromolyn (2 ml, 0.11 mg/ml) was applied topically at 10 min of the normoxic control and immediately before the hypoxia and recovery periods.
In a few experiments of each protocol, the muscles were prepared for histological examination of mast cells. In these cases, the cremaster was removed at the end of the experimental period (i.e., systemic hypoxia, cremaster hypoxia, etc.) before the onset of the recovery period.
Statistics. Data are presented as means Ϯ SE. Data after a given treatment were compared with the corresponding pretreatment data by using a t-test for paired samples. Intergroup comparisons were made with a one-way ANOVA followed by the Bonferroni test for multiple comparisons. A P value of Յ0.05 was considered to indicate a significant difference.
RESULTS
As expected from our laboratory's previous study (16) , systemic hypoxia resulted in a rapid and reversible increase in leukocyte adherence to cremaster venular endothelium (Fig. 1, top, n ϭ 6) . Reduction of arterial blood PO 2 from 89 Ϯ 3 to 31 Ϯ 1 Torr (Fig. 1,  bottom) , was accompanied by a decrease in Pm O 2 from 32 Ϯ 3 Torr immediately before the onset of hypoxia to 7 Ϯ 1 Torr at 10 min of hypoxia (Fig. 1, bottom, n ϭ 6) . Pretreatment with the mast cell stabilizer cromolyn completely prevented the increase in leukocyte-endothelial adherence associated with hypoxia ( Fig. 1, top , n ϭ 6) without modifying the Pm O 2 response to systemic hypoxia (Fig. 1, bottom, n ϭ 5) . Figure 2 shows microphotographs of cremaster mast cells dyed with toluidine blue. Activation of cremaster mast cells by hypoxia is demonstrated by mast cell degranulation shown in the left panel. In contrast, no granules are evident in the cremaster mast cells of an animal exposed to hypoxia and pretreated with cromolyn.
Selective cremaster hypoxia in the presence of systemic normoxia was not associated with increased leukocyte-endothelial adherence (Fig. 3, top, n ϭ 6 ). Equilibration of the cremaster with 95% N 2 -5% CO 2 while the animals breathed room air produced a rapid and sustained decrease in cremaster Pm O 2 , which reached 9 Ϯ 2 Torr at 1 min and remained at 7 Ϯ 1 Torr at 10 min of hypoxia (Fig. 3, bottom, n ϭ 6 ). Pa O 2 values (Fig.  3, bottom) remained essentially unchanged during cremaster hypoxia. Topical application of the mast cell activator compound 48/80 during cremaster hypoxia resulted in a rapid and sustained increase in leukocyteendothelial adherence (Fig. 3, top, n ϭ 6) , which was effectively blocked by pretreatment with the mast cell stabilizer cromolyn applied topically (Fig. 3, top, n ϭ 6 ). Neither compound 48/80 nor cromolyn modified the Pm O 2 response to cremaster equilibration with 95% N 2 -5% CO 2 (Fig. 3) . Cremaster mast cells did not show evidence of degranulation during cremaster hypoxia at normoxic systemic PO 2 (Fig. 4, left panel) ; however, topical application of compound 48/80 under the same conditions resulted in mast cell degranulation (Fig. 4,  middle) , which was blocked by cromolyn (Fig. 4, right) .
Systemic hypoxia produced a significant increase in leukocyte-endothelial adherence in cremaster venules (Fig. 5, top) even though cremaster Pm O 2 was maintained between 62 and 68 Torr throughout the experiment by equilibration of the cremaster with 10% O 2 -5% CO 2 -85% N 2 (Fig. 5, bottom) . Topical application of cromolyn completely prevented the increase in leukocyte-endothelial adherence (Fig. 5, top) . Cremaster Pm O 2 values during cromolyn treatment (Fig. 5 , bottom) were not significantly different from those seen in the untreated rats. Cremaster mast cells showed degranulation in rats of the systemic hypoxia/cremaster normoxia group (Fig. 6, left) , which was prevented by topical pretreatment with cromolyn (Fig. 6, right) .
DISCUSSION
The results obtained in the present experiments confirm our earlier demonstration of a dissociation between cremaster Pm O 2 and hypoxia-induced adherence of leukocytes to the endothelium of cremaster venules: leukocyteendothelial adherence occurred only when arterial blood PO 2 was reduced, independent of the value of cremaster Pm O 2 (15) . The data further suggest that cremaster mast cells were activated only under conditions of systemic hypoxia and that cremaster mast cell activation was also independent of the cremaster Pm O 2 value.
In this study, activation or inhibition of mast cells was inferred from the effects of cromolyn, a mast cell stabilizer, and compound 48/80, a mast cell activator, on the changes in leukocyte-endothelial adherence produced by the various experimental interventions. Both of these agents have been used widely for these purposes. Both cromolyn and compound 48/80 were applied topically so that only cremaster mast cells were influenced. The effects of cromolyn and compound 48/80 on leukocyte-endothelial adhesive interactions were correlated with histological images of mast cells obtained when the cremaster muscles were exposed to the different experimental conditions and the tissue samples obtained before the recovery periods were initiated.
We have previously observed that mast cells play a key role in the hypoxia-induced microvascular inflammation in the mesentery (19) : mesenteric mast cells degranulate during hypoxia, and blockade of mast cell degranulation prevents or attenuates the inflammatory response. The data presented here show that mast cells play a similar role in the microvascular response to hypoxia in skeletal muscle. Recent preliminary data (10) show that brain mast cells also degranulate during reduction of inspired PO 2 . Taken together, these results suggest that mast cell activation is a generalized response to systemic hypoxia. In the present experiments, cromolyn prevented the increase in leukocyteendothelial adherence produced during systemic hypoxia (Fig. 1) , suggesting that cremaster mast cells are activated in this condition and that mast cell activation mediates the increase in leukocyte-endothelial adhesive interactions of systemic hypoxia. This is supported by the observation of cremaster mast cell degranulation in the hypoxic untreated rats and its absence in the hypoxic rats pretreated with cromolyn (Fig. 2) .
The absence of leukocyte-endothelial adherence during local cremaster hypoxia, its increase with topical application of compound 48/80 (Fig. 3) , and the blockade of the effects of compound 48/80 with cromolyn indicate that, under the experimental conditions required to produce local cremaster hypoxia and systemic normoxia, mast cells are inactive but can be activated if adequately stimulated. The histological images shown in Fig. 4 are consistent with this conclusion: mast cells show no evidence of degranulation during local cremaster hypoxia and degranulate in response to topical application of compound 48/80; furthermore, topical cromolyn blocks this effect of compound 48/80 on mast cell degranulation (Fig. 4) . The correlation between changes in mast cell activation and leukocyte-endothelial adherence indicate that the effects of compound 48/80 and of cromolyn on leukocyte-endothelial adhesive interactions are mediated through changes in mast cell activity. When cremaster Pm O 2 was maintained elevated during systemic hypoxia, leukocytes adhered to the venular endothelium to the same extent as when cremaster Pm O 2 was reduced in systemic hypoxia (compare Figs. 1 and 5 ). This response was also blocked by cromolyn, suggesting that cremaster mast cell activation during systemic hypoxia occurs independently of whether cremaster Pm O 2 is elevated or reduced.
The overall weight of the data presented in this study supports the idea that local PO 2 in the cremaster is not the specific stimulus that sets in motion the microvascular inflammatory cascade that follows a reduction in inspired PO 2 , since the early steps of this process, i.e., stimulation of mast cells and subsequent increase in leukocyte-endothelial adhesive interactions, can be observed when cremaster PmO 2 is elevated; conversely, reduction of local Pm O 2 fails to set the inflammatory cascade in motion if Pa O 2 remains within the normal range. These results are consistent with our previous observations that a reduction in cremaster Pm O 2 , produced by mechanical restriction of blood flow to the cremaster in the presence of normal Pa O 2 , also failed to elicit increased leukocyte-endothelial adherence (15) .
Our data are consistent with the idea that the microvascular inflammatory response to systemic hypoxia is mediated through the release of an intermediary substance, which starts the inflammatory cascade by inducing activation of mast cells. This study, however, does not provide evidence regarding the nature of such substance. The time course of the response suggests an agent that is stored or is rapidly synthesized; the widespread nature of the microvascular inflammation suggests a central site of release such as the lungs. It is clear that further study is necessary to determine the existence and nature of this mediator.
The data presented in this study are in apparent conflict with in vitro observations of increased leukocyteendothelial interactions in response to hypoxia. The microvascular response observed when intact animals are exposed to systemic hypoxia is quite rapid, with significant increases in ROS levels (20) , mast cell degranulation (19) , and leukocyte rolling and adherence to venular endothelium (22) occurring within 5 min of hypoxic exposure. In general, in vitro studies of leukocyte-endothelial adhesive interactions have been carried out by using longer hypoxic exposure periods (2, 3, 11, 12, 15, 17) . It is possible that different mechanisms operate at various times after the onset of hypoxia and that low PO 2 could influence slowly developing mechanisms, which do not operate within the time frame of this study.
In summary, the present studies indicate that mast cells participate in the cremaster microvascular inflammation that follows a reduction of inspired PO 2 in the rat. The results indicate that mast cell stimulation occurs only when systemic Pa O 2 is reduced and is independent of the local Pm O 2 . These data are consistent with the presence of an intermediary released from a distant site under conditions of systemic hypoxia, and which sets in motion the initial microvascular inflammatory response to hypoxia.
